Cyclooxygenase-2 is induced by p38 MAPK and promotes cell survival

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1999-2004

  Parente, Rosanna ^a   Trifirò, Elisabetta ^a   Cuozzo, Francesca ^a   Valia, Sandro ^a   Cirone, Mara ^a   Di Renzo, Livia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Arachidonic acid; Cyclooxygenase 2; Monensin; p38 MAPK; Survival pathway

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLSALICYLIC ACID; ANISOMYCIN; CELECOXIB; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MONENSIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LYMPHOMA CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL CYCLE CHECKPOINTS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOOXYGENASE 2; ENZYME INDUCTION; G1 PHASE; HUMANS; MONENSIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 84876268241     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2308     Document Type: Article

References (40)

1. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN and Hay N: The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11: 701-713, 1997. (Pubitemid 27157159)
2. Datta SR, Brunet A and Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
3. Finkel T and Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
4. Martindale JL and Holbrook NJ: Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15, 2002. (Pubitemid 34587382)
5. Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849, 2004. (Pubitemid 38638846)
6. Widmann C, Gibson S, Jarpe MB and Johnson GL: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180, 1999. (Pubitemid 29056951)
7. Kyriakis JM and Avruch J: Mammalian MAPK signal transduction patyhways activated by stress and inflammation: a 10-year update. Physiol Rev 92: 689-737, 2012.
8. Lewis TS, Shapiro PS and Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 74: 49-139, 1998. (Pubitemid 28193546)
9. Wu J, Suzuki H, Akhand AA, Zhou YW, Hossain K and Nakashima I: Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells. Cell Signal 14: 509-515, 2002. (Pubitemid 34230586)
10. Platanias LC: MAP kinase signaling pathways and hematologic malignancies. Blood 101: 4667-4679, 2003.
11. 2-terminal kinase (SAPK/JNK) activity and p38 mitogen-activated protein kinase activity by a calcium-independent mechanism. J Biol Chem 272: 13653-13659, 1997.
12. Raciti M, Lotti LV, Valia S, Pulcinelli FM and Di Renzo L: JNK2 is activated during ER stress and promotes cell survival. Cell Death Dis 3: e429, 2012.
13. Okamoto S, Krainc D, Sherman K and Lipton SA: Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc Natl Acad Sci USA 97: 7561-7566, 2000. (Pubitemid 30431503)
14. + across liposome membrane. Biochim Biophys Acta 1064: 103-110, 1991.
15. + antiport and intracellular pH in the regulation of HL-60 cell apoptosis. Biochim Biophys Acta 1269: 122-128,1995.
16. Park WH, Lee MS, Park K, Kim ES, Kim BK and Lee YY: Monensin-mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis. Int J Cancer 101: 235-242, 2002. (Pubitemid 34970890)
17. Park WH, Seol JG, Kim ES, et al: Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. Br J Haematol 119: 400-407, 2002. (Pubitemid 35365490)
18. Iljin K, Ketola K, Vainio P, et al: High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res 15: 6070-6078, 2009.
19. Ketola K, Hilvo M, Hyotylainen T, et al: Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer 106: 99-106, 2012.
20. Sundstrom C and Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17: 565-577, 1976.
21. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
22. Cirone M, Di Renzo L, Lotti LV, et al: Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91. PLoS One 7: e31732, 2012.
23. Matusali G, Arena G, De Leo A, Di Renzo L and Mattia E: Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds. Mol Cancer 8: 18, 2009.
24. Marfè G, Morgante E, Di Stefano C, Di Renzo L, et al: Sorbitol-induced apoptosis of human leukemia is mediated by caspase activation and cytochrome c release. Arch Toxicol 82: 371-377, 2008.
25. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL and Smith WL: Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902-10908, 1995.
26. Davies SP, Reddy H, Caivano M and Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
27. Smith WL, DeWitt DL and Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000.
28. Chen W, Tang Q, Gonzales MS and Bowden GT: Role of p38 MAPK and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression. Oncogene 20: 3921-3926, 2001. (Pubitemid 32646203)
29. Hung JH, Su IJ, Lei HY et al: Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem 279: 46384-46392, 2004.
30. Rizzo MT, Pudlo N, Farrell L and Leaver A: Specificity of arachidonic acid-induced inhibition of growth and activation of c-jun kinases and p38 mitogen-activated protein kinase in hematopoietic cells. Prostaglandins Leukot Essent Fatty Acids 66: 31-40, 2002. (Pubitemid 34717686)
31. Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK and Tlsty TD: p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Res 65: 1792-1799, 2005. (Pubitemid 40478606)
32. Hendrickx N, Volanti C, Moens U, et al: Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J Biol Chem 278: 52231-52239, 2003. (Pubitemid 38035811)
33. + influx and arachidonic acid release in FRTL-5 thyroid cells. J Investig Med 47: 388-396, 1999.
34. Smith WL and Langenbach R: Why there are two cyclooxygenase isozymes. J Clin Invest 107: 1491-1495, 2001. (Pubitemid 32574631)
35. Reddy BS, Rao CV and Seibert K: Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56: 4566-4569, 1996. (Pubitemid 26338047)
36. Tsujii M, Kawano S and DuBois R: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340, 1997. (Pubitemid 27157312)
37. Oshima M, Dinchuk JE, Kargman SL, et al: Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809, 1996. (Pubitemid 26404280)
38. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H and Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58: 4997-5001, 1998. (Pubitemid 28521147)
39. Chan G, Boyle JO, Yang EK, Zhang F, et al: Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991-994,1999. (Pubitemid 29135955)
40. Higashi Y, Kanekura T and Kanzaki T: Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression. Int J Cancer 86: 667-671, 2000. (Pubitemid 30249877)